Abstract
Fexofenadine (Allegra. ®180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine- induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test.
Original language | English |
---|---|
Pages (from-to) | S329-S332 |
Journal | Annals of Dermatology |
Volume | 23 |
Issue number | SUPPL. 3 |
DOIs | |
State | Published - Dec 2011 |
Keywords
- Basophil degranulation test
- Drug eruotion/etiology
- Fexofenadine
- Histamine H1 antagonist/adverse effects